Kitov Reports New Data Demonstrating KIT-302 Has Beneficial Effects on Kidney Function
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced newly available data from its successfully completed Phase III study of KIT-302 suggest beneficial effects on kidney(renal) function. Damage to renal function is a serious side effect of NSAIDs.
View full press release